Colorado BioScience Association Welcomes Amy Berenbaum Goodman as Vice President and Counsel for Policy + Advocacy
By: Colorado BioScience Association Date: 12/15/2022
Goodman to Advance Federal and State Policies that Support Life Sciences Innovation
Denver – Colorado BioScience Association (CBSA) announces the appointment of Amy Berenbaum Goodman as Vice President and Counsel for Policy + Advocacy. An attorney who holds a Master of Bioethics, Goodman will develop strategies to support a pro-business environment for health innovation in Colorado. Working with the President and CEO and CBSA Board of Directors, she will advance state and federal policies that support the companies and organizations in Colorado’s life sciences ecosystem and the patients they serve.
“Colorado BioScience Association warmly welcomes Amy Berenbaum Goodman as Vice President and Counsel for Policy + Advocacy,” said Elyse Blazevich, CBSA President and CEO. “With the momentum of Colorado’s life sciences community, there’s a critical need for her deep expertise in healthcare law and policy, and skill in building successful coalitions to advance pro-innovation policies for our ecosystem.”
Amy will draw on her background in healthcare law and policy, regulatory compliance, and member-based organizations to advocate for policies that support the health and growth of life sciences in Colorado. She will champion issues critical to the ecosystem, including Capital + Growth, workforce cultivation, favorable tax and regulatory policies, incentives for innovation, and patient access to healthcare innovation.
“I look forward to working with Elyse Blazevich, the CBSA Board of Directors, and our team to lead Policy + Advocacy for CBSA and Colorado’s life sciences community,” said Amy Berenbaum Goodman, CBSA Vice President and Counsel for Policy + Advocacy. “I am proud to champion the ecosystem’s success and advance Colorado’s reputation as a leading national and international hub for life sciences innovation. This new role builds on my career-long commitment to promoting science and evidence-based policies and protecting public health.”
Goodman brings deep expertise in healthcare law, Policy + Advocacy to support health innovators and member-based organizations. She’s respected for working with diverse stakeholder groups to build consensus on policies that address stakeholder needs and support patients.
Before joining CBSA, Amy advocated for physicians, residents, and medical students as the Senior Director of Policy at Colorado Medical Society. Previously, she served as Senior
Manager of Corporate Compliance at DaVita Kidney Care and as an Associate Attorney focused on healthcare law at Hall, Render, Killian, Heath & Lyman.
Goodman earned a J.D. from the University of Denver Sturm College of Law, where she was a Chancellor’s Scholar and graduated Order of the Coif. She holds an M.B.E. (Master of Bioethics) from the University of Pennsylvania Perelman School of Medicine and a B.A. in health & societies from the University of Pennsylvania, graduating magna cum laude.
About Colorado BioScience Association
Colorado BioScience Association (CBSA) creates co-opportunity for the Colorado life sciences community. CBSA champions a collaborative life sciences ecosystem and advocates for a supportive business climate. From concept to commercialization, member companies and organizations drive global health innovations, products and services that improve and save lives. The association leads Capital and Growth, Education and Networking, Policy and Advocacy, and Workforce Cultivation to make its members stronger, together. Learn more: cobioscience.com
# # #
Primavera Group for Colorado BioScience Association